First Trust Nasdaq Pharmaceuticals ETF (FTXH): Price and Financial Metrics ETF
FTXH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $28.31 | 52-week high | $29.72 |
| Prev. close | $28.34 | 52-week low | $23.85 |
| Day low | $28.31 | Volume | 331 |
| Day high | $28.31 | Avg. volume | 5,418 |
| 50-day MA | $28.81 | Dividend yield | 1.56% |
| 200-day MA | $27.78 |
FTXH Stock Price Chart Interactive Chart >
First Trust Nasdaq Pharmaceuticals ETF (FTXH) ETF Bio
The investment objective of the First Trust Nasdaq Pharmaceuticals ETF seeks to select the most liquid eligible securities within the pharmaceutical sector from the Nasdaq US Benchmark Index and then rank them on the three factors - volatility, value and growth. The securities that are selected for each index are weighted based upon their combined score of the three factors.
FTXH ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.6% |
| Underlying Index | Nasdaq US Smart Pharmaceuticals Index |
| Asset Class | Equity |
| Sector | Large Cap |
| Assets Under Management (AUM) | 17.00K |
| Net Asset Value (NAV) | $28.34 |
| Options? | Yes |
| Total Holdings | 52 |
FTXH Top Holdings
| Symbol | Company | % of Total |
| BMY | Bristol-Myers Squibb Company | 8.39% |
| ABBV | AbbVie Inc. | 7.8% |
| PFE | Pfizer Inc. | 7.33% |
| JNJ | Johnson & Johnson | 7.24% |
| MRK | Merck & Co. Inc. | 6.49% |
| GILD | Gilead Sciences Inc. | 4.22% |
| UTHR | United Therapeutics Corporation | 3.73% |
| ZTS | Zoetis Inc. | 3.66% |
| CAH | Cardinal Health Inc. | 3.62% |
| VTRS | Viatris Inc. | 3.61% |
FTXH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
FTXH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||